Literature DB >> 15569068

Washing of cord blood grafts after thawing: high cell recovery using an automated and closed system.

L Rodríguez1, C Azqueta, S Azzalin, J García, S Querol.   

Abstract

BACKGROUND AND OBJECTIVES: Cord blood (CB) progenitor cells are an alternative source of haematopoietic stem cells for bone marrow reconstitution. The critical importance of cell dose in the clinical outcome has motivated the need to develop techniques aimed at reducing cell losses and increasing reproducibility. This aim of this study was to evaluate an automated CB washing protocol of thawed cord blood units using the Sepax device.
MATERIALS AND METHODS: After an initial 1:1 dilution using a dextran/albumin-containing buffer, the cells were washed in order to obtain a final product ready for transplantation. The automatic method was compared with the conventional manual washing procedure. Blood samples were taken after thawing and after washing. The processing time, viability and mean recovery of nucleated cells (TNC) and progenitors were determined.
RESULTS: The automatic procedure resulted in a median recovery of 93% CD34+ cells and 89% TNC; no significant differences were observed between methods. In addition, median viability, as assessed by annexin V and 7-aminoactinomycin D (7-AAD), was 98% and 94%, respectively, within CD34+ cells.
CONCLUSIONS: The automatic washing method described is as effective as the manual method in terms of viability and progenitor cells recovery, but faster and easier for the operators to perform. Overall, our data suggest that the automatic method is safe and suitable for the routine washing of thawed CB grafts in the clinic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569068     DOI: 10.1111/j.1423-0410.2004.00550.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

Review 1.  Cryopreservation of hematopoietic stem cells.

Authors:  David Berz; Elise M McCormack; Eric S Winer; Gerald A Colvin; Peter J Quesenberry
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

2.  Cell therapy of pseudarthrosis.

Authors:  Ricardo Bastos Filho; Simone Lermontov; Radovan Borojevic; Paulo Cezar Schott; Vinicius Schott Gameiro; José Mauro Granjeiro
Journal:  Acta Ortop Bras       Date:  2012       Impact factor: 0.513

Review 3.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Authors:  Z Shu; S Heimfeld; D Gao
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

4.  Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR.

Authors:  Richard C Duggleby; Hoi Pat Tsang; Kathryn Strange; Alasdair McWhinnie; Abigail A Lamikanra; David J Roberts; Diana Hernandez; J Alejandro Madrigal; Robert D Danby
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.